Please Note Before Ordering:
-
Non-Stock / Final Sale: This item is final sale and cannot be returned, refunded, or cancelled after purchase due to Health Canada regulations.
-
Cold-Weather Shipping: Temperature-controlled delivery is used during cold months, an ambient shipping fee will be applied to this item.
-
Professional Use Only: This is a restricted prescription drug for authorized medical professionals. Please include your professional License number in the comments section of the order.
Mydriacyl 1% Ophthalmic Solution
Mydriacyl 1% Ophthalmic Solution is a professional-grade, prescription-only diagnostic agent formulated to facilitate comprehensive ocular examinations and diagnostic refraction procedures. Packaged in a convenient 15 mL dispenser bottle under Canadian Drug Identification Number (DIN) 00001007, this sterile topical solution is an essential asset for optometric, ophthalmic, and medical clinics across Canada.
Key Therapeutic Actions
- Rapid Mydriasis: Effectively dilates the pupil to allow an unobstructed, clear view of the retina, optic nerve head, and internal structures of the eye.
- Efficient Cycloplegia: Temporarily paralyzes the ciliary muscle, blocking accommodation to ensure accurate diagnostic refraction measurements.
Product Specifications & Features
- Active Ingredient: Tropicamide 1% w/v (Anticholinergic / Mydriatic / Cycloplegic agent).
- Format: 15 mL sterile dropper bottle optimized for precise, waste-free administration.
- Compliance: Fully regulated under Health Canada DIN 00001007 for authorized clinical and professional clinical environments.
- Preservative System: Formulated with Benzalkonium chloride 0.01% as an antimicrobial agent.
Professional Usage & Clinical Safety Notes
- Contact Lens Protocol: Soft contact lenses must be removed prior to instillation as the preservative benzalkonium chloride can be absorbed by the lens material. Lenses may be reinserted 15 minutes post-application.
- Post-Examination Caution: Patients will experience temporary blurred vision and significant light sensitivity (photophobia). Advise patients not to drive or operate machinery until the effects have fully resolved.
- Contraindications: Strictly contraindicated for patients with known or suspected narrow-angle glaucoma and infants under 3 months of age. For topical ophthalmic use only; do not inject.
Please Note: This is a prescription-regulated medical product. Verification of clinical licensure or professional account registration is required prior to shipping.
